Rare Neoplasm — Trials

Rare Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

361 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04044859	ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS)	active not recruiting	Phase 1	120	USWM CT, LLCINDUSTRY	3	Sep 23, 2026	clinicaltrials
NCT03386513	Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN	active not recruiting	Phase 1 / Phase 2	179	AbbVieINDUSTRY	6	Sep 4, 2026	clinicaltrials